http://www.fpnotebook.com/
Cephalosporin
- General
- Spectrum changes from first to third generation
- First Generation: Better Gram Positive Cocci coverage
- Third Generation: Better Gram Negative Rod coverage
- Spectrum changes from first to third generation
- Contraindications
- Drug allergy to other Cephalosporin
- Type I Hypersensitivity Reaction to a Penicillin
- Class: First Generation Cephalosporins
- Oral Agents
- Cephalexin (Keflex)
- Cephradine (Velosef)
- Cefadroxil (Duricef)
- Parenteral Agents
- Organisms covered
- Oral Agents
- Class: Second Generation Cephalosporins
- Second Generation Broad-spectrum Cephalosporins
- Oral Agents
- Loracarbef (Lorabid)
- Cefprozil (Cefzil)
- Cefuroxime (Ceftin, Zinacef)
- Cefaclor (Ceclor)
- Organisms Covered
- Oral Agents
- Second Generation Anti-anaerobe Cephalosporins
- Parenteral Agents
- Organisms Covered
- Bacteroides fragilis
- Second Generation Broad-spectrum Cephalosporins
- Class: Third Generation Cephalosporins
- Third Generation Broad-Spectrum Cephalosporins
- Oral agents
- Cefixime (Suprax)
- Cefpodoxime (Vantin)
- Parenteral agents
- Cefotaxime (Claforan)
- Ceftizoxime (Cefizox)
- Ceftriaxone (Rocephin)
- Organisms Covered
- Gram Positive Cocci
- EKP Gram Negative Bacteria
- ESP Gram Negative Bacteria
- No Pseudomonas activity
- Oral agents
- Third Generation Anti-Pseudomonal Cephalosporins
- Agents
- Ceftazidime (Fortaz)
- Organisms Covered
- Pseudomonas
- EKP Gram Negative Bacteria
- ESP Gram Negative Bacteria
- Poor Gram Positive Cocci coverage
- No Coccobacilli coverage
- Agents
- Third Generation Broad-Spectrum Cephalosporins
- Dosing: Adults
- Almost all Cephalosporins
- Typical Dose: 1-2 grams IV q8h
- Exceptions
- Ceftriaxone 1-2 grams IV q24 hours
- Cefotetan 1-2 grams IV q12 hours
- Almost all Cephalosporins
- Dosing: Children
- Almost all Cephalosporins
- Typical dose: 100-200 mg/kg/day divided q8 hours
- Exceptions
- Ceftriaxone 75-100 mg/kg/day q24 hours
- Almost all Cephalosporins
- Reducing Adverse Effects
Cephalosporins (C0007732) | |
|---|---|
| Definition (MSH) | A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. |
| Definition (CSP) | group of broad spectrum antibiotics which share the nucleus 7-aminocephalosporanic acid; antibacterial activity results from inhibition of the cross linking of peptidoglycan units in the cell wall. |
| Definition (NCI) | A family of antibiotic drugs that is used to treat a wide variety of bacterial infections. |
| Definition (NCI) | A class of broad-spectrum antibiotics first isolated from the Mediterranean fungus Acremonium (Cephalosporium acremonium). Cephalosporins inhibit mucopeptide synthesis by binding to penicillin binding proteins, causing inhibition of bacterial cell wall synthesis. (NCI) |
| Concepts | Organic Chemical (T109) , Antibiotic (T195) |
| MSH | D002511 |
| English | Cephalosporin, Cephalosporin -class of antibiotic-, Cephalosporin Antibiotic, Cephalosporin Antibiotics, Cephalosporins |
| Parent Concepts | Monobactams (C0026458), Thiazines (C0039858), beta-Lactams (C0282215), Antibiotics (C0003232), Microbicides (C1136254) |
| Sources | CSP, LCH, MSH, NCI, NDFRT, SCTSPA, SNOMEDCT Derived from the NIH UMLS (Unified Medical Language System) |
